Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalActive in the last 2 years

Yimin Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8102-1457; OpenAlex author ID A5113166300. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma. Co-author DOI 10.1002/ptr.8296↗
  2. Post-translational modification of CDK1-STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties. First author DOI 10.1186/s13578-023-01118-z↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liping Cao · 2 shared papers, 2023–2024 · strength 0.42
  2. Shengnan Jia · 1 shared paper, 2024 · strength 0.24
  3. Dafei Xie · 1 shared paper, 2024 · strength 0.24
  4. Guoping Ding · 1 shared paper, 2023 · strength 0.18
  5. Xiaodong Xu · 1 shared paper, 2023 · strength 0.18
  6. Shengnan Jia · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.